{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:55:59Z","timestamp":1791860159467,"version":"4.3.4"},"reference-count":35,"publisher":"EDITORA SCIENTIFIC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Bras. Psiquiatr."],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:p>OBJECTIVE: In this report, we aimed to evaluate the effect of add-on N-acetylcysteine (NAC) on depressive symptoms and functional outcomes in bipolar disorder. To that end, we conducted a secondary analysis of all patients meeting full criteria for a depressive episode in a placebo controlled trial of adjunctive NAC for bipolar disorder. METHOD: Twenty-four week randomised clinical trial comparing adjunctive NAC and placebo in individuals with bipolar disorder experiencing major depressive episodes. Symptomatic and functional outcome data were collected over the study period. RESULTS: Seventeen participants were available for this report. Very large effect sizes in favor of NAC were found for depressive symptoms and functional outcomes at endpoint. Eight of the ten participants on NAC had a treatment response at endpoint; the same was true for only one of the seven participants allocated to placebo. DISCUSSION: These results indicate that adjunctive NAC may be useful for major depressive episodes in bipolar disorder. Further studies designed to confirm this hypothesis are necessary.<\/jats:p>","DOI":"10.1590\/s1516-44462011000400011","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:59:11Z","timestamp":1324515551000},"page":"374-378","source":"Crossref","is-referenced-by-count":98,"title":["N-acetylcysteine for major depressive episodes in bipolar disorder"],"prefix":"10.47626","volume":"33","author":[{"given":"Pedro V","family":"Magalh\u00e3es","sequence":"first","affiliation":[{"name":"National Institute for Translational Medicine; Hospital de Cl\u00ednicas de Porto Alegre,  Brazil; Deakin University,  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ol\u00edvia M","family":"Dean","sequence":"additional","affiliation":[{"name":"Deakin University,  Australia; Deakin University,  Australia; Mental Health Research Institute of Victoria,  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley I","family":"Bush","sequence":"additional","affiliation":[{"name":"Deakin University,  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"Copolov","sequence":"additional","affiliation":[{"name":"Monash University,  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gin S","family":"Malhi","sequence":"additional","affiliation":[{"name":"University of Sydney,  Australia; CADE Clinic,  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Kohlmann","sequence":"additional","affiliation":[{"name":"Deakin University,  Australia; Mental Health Research Institute of Victoria,  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Jeavons","sequence":"additional","affiliation":[{"name":"Deakin University,  Australia; La Trobe University,  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Schapkaitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Anderson-Hunt","sequence":"additional","affiliation":[{"name":"Deakin University,  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[{"name":"National Institute for Translational Medicine; Hospital de Cl\u00ednicas de Porto Alegre,  Brazil; Deakin University,  Australia; Mental Health Research Institute of Victoria,  Australia; Orygen Youth Health Research Centre,  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27448","reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4088\/JCP.8125tx12c","article-title":"Nosology, diagnostic challenges, and unmet needs in managing bipolar disorder","volume":"71","author":"Ketter TA","year":"2010","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10673221003747955","article-title":"Bipolar depression: overview and commentary","volume":"18","author":"Baldessarini RJ","year":"2010","journal-title":"Harv Rev Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/1067-3229","issn-type":"print"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archpsyc.62.12.1322","article-title":"Psychosocial disability in the course of bipolar I and II disorders -A prospective, comparative, longitudinal study","volume":"62","author":"Judd LL","year":"2005","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000228249","article-title":"Functioning and disability in bipolar disorder: An extensive review","volume":"78","author":"Sanchez-Moreno J","year":"2009","journal-title":"Psychother Psychosom","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3190","issn-type":"print"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1176\/ajp.2006.163.9.1561","article-title":"Prevalence and effects of mood disorders on work performance in a nationally representative sample of U: S. workers","volume":"163","author":"Kessler RC","year":"2006","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3810\/pgm.2010.07.2172","article-title":"Bipolar disorder: an update","volume":"122","author":"El-Mallakh RS","year":"2010","journal-title":"Postgrad Med","ISSN":"https:\/\/id.crossref.org\/issn\/0032-5481","issn-type":"print"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hup.390","article-title":"Serological observations in patients suffering from acute manic episodes","volume":"17","author":"Wadee AA","year":"2002","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk M","year":"2011","journal-title":"Neurosci Biobehav Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0149-7634","issn-type":"print"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/mp.2009.112","article-title":"A systemic toxicity index developed to assess peripheral changes in mood episodes","volume":"15","author":"Kapczinski F","year":"2010","journal-title":"Mol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/1359-4184","issn-type":"print"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski F","year":"2011","journal-title":"J Psychiatr Res","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3956","issn-type":"print"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neubiorev.2007.10.005","article-title":"Allostatic load in bipolar disorder: Implications for pathophysiology and treatment","volume":"32","author":"Kapczinski F","year":"2008","journal-title":"Neurosci Biobehav Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0149-7634","issn-type":"print"},{"issue":"23","key":"ref12","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.2174\/092986709788803060","article-title":"A Role for Glutathione in the Pathophysiology of Bipolar Disorder and Schizophrenia: Animal Models and Relevance to Clinical Practice","volume":"16","author":"Dean OM","year":"2009","journal-title":"Curr Med Chem","ISSN":"https:\/\/id.crossref.org\/issn\/0929-8673","issn-type":"print"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean O","year":"2011","journal-title":"J Psychiatry Neurosci","ISSN":"https:\/\/id.crossref.org\/issn\/1180-4882","issn-type":"print"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tips.2008.05.001","article-title":"Glutathione: a novel treatment target in psychiatry","volume":"29","author":"Berk M","year":"2008","journal-title":"Trends Pharmacol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0165-6147","issn-type":"print"},{"issue":"1-3","key":"ref15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejphar.2010.09.035","article-title":"Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-onetreated rats","volume":"649","author":"Choy KHC","year":"2010","journal-title":"Eur J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2999","issn-type":"print"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pbb.2010.08.013","article-title":"Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice","volume":"97","author":"Dean O","year":"2010","journal-title":"Pharmacol Biochem Behav","ISSN":"https:\/\/id.crossref.org\/issn\/0091-3057","issn-type":"print"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1399-5618.2010.00834.x","article-title":"Assessing oxidative pathway genes as risk factors for bipolar disorder","volume":"12","author":"Fullerton JM","year":"2010","journal-title":"Bipolar Disord"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1017\/S1461145711000617","article-title":"Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders","volume":"14","author":"Gawryluk JW","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder -A double-blind randomized placebo-controlled trial","volume":"64","author":"Berk M","year":"2008","journal-title":"Biol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1601-5215.2011.00530.x","volume":"23","author":"Magalh\u00e3es PV","year":"2011","journal-title":"Acta Neuropsychiatr"},{"issue":"1-3","key":"ref21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jad.2010.08.001","article-title":"N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial","volume":"129","author":"Magalhaes PV","year":"2011","journal-title":"J Affect Disord","ISSN":"https:\/\/id.crossref.org\/issn\/0165-0327","issn-type":"print"},{"key":"ref22","first-page":"22","article-title":"MINI -Mini International Neuropsychiatric Interview - English Version 5: 0.0 - DSM-IV","volume":"59","author":"Sheehan DV","year":"1998","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1399-5618.2007.00536.x","article-title":"The bipolar depression rating scale (BDRS): Its development, validation and utility","volume":"9","author":"Berk M","year":"2007","journal-title":"Bipolar Disord"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.2004.00412.x","article-title":"Scale matters: the need for a Bipolar Depression Rating Scale (BDRS)","volume":"422","author":"Berk M","year":"2004","journal-title":"Acta Psychiatr Scand Suppl","ISSN":"https:\/\/id.crossref.org\/issn\/0065-1591","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"New depression scale designed to be sensitive to change","volume":"134","author":"Montgomery SA","year":"1979","journal-title":"Br J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1250","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"Rating scale for mania - reliability, validity and sensitivity","volume":"133","author":"Young RC","year":"1978","journal-title":"Br J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1250","issn-type":"print"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing MK","year":"1997","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archpsyc.1987.01800180050009","article-title":"The longitudinal interval follow-up evaluation - a comprehensive method for assessing outcome in prospective longitudinal studies","volume":"44","author":"Keller MB","year":"1987","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"issue":"2","key":"ref29","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire - a new measure","volume":"29","author":"Endicott J","year":"1993","journal-title":"Psychopharmacol Bull","ISSN":"https:\/\/id.crossref.org\/issn\/0048-5764","issn-type":"print"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","article-title":"The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders","volume":"11","author":"Tohen M","year":"2009","journal-title":"Bipolar Disord"},{"issue":"1-2","key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2005.04.002","article-title":"The bootstrap: A technique for data-driven statistics. Using computer-intensive analyses to explore experimental data","volume":"359","author":"Henderson AR","year":"2005","journal-title":"Clin Chim Acta","ISSN":"https:\/\/id.crossref.org\/issn\/0009-8981","issn-type":"print"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-185X.2007.00027.x","article-title":"Effect size, confidence interval and statistical significance: a practical guide for biologists","volume":"82","author":"Nakagawa S","year":"2007","journal-title":"Biological Reviews"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4088\/JCP.v68n0810","article-title":"Pramipexole in psychiatry: a systematic review of the literature","volume":"68","author":"Aiken CB","year":"2007","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biopsych.2004.03.013","article-title":"Pramipexole for bipolar II depression: a placebo-controlled proof of concept study","volume":"56","author":"Zarate CA Jr","year":"2004","journal-title":"Biol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/appi.ajp.161.3.564","article-title":"Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression","volume":"16","author":"Goldberg JF","year":"2004","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"}],"container-title":["Revista Brasileira de Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbp\/v33n4\/v33n4a11.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T16:10:59Z","timestamp":1654531859000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462011000400011&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1516-44462011000400011"],"URL":"https:\/\/doi.org\/10.1590\/s1516-44462011000400011","relation":{},"ISSN":["1516-4446"],"issn-type":[{"value":"1516-4446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}